Larson Applauds Announcement of First Drugs Selected for Medicare Price Negotiation, More than 120,000 CT Residents To Benefit

East Harford, CT – Today, Rep. John B. Larson (CT-01) released the following statement after the Biden Administration announced the first ten prescription drugs selected for Medicare price negotiation. Larson voted for the Inflation Reduction Act in 2022 as a member of the Ways and Means Committee and for its final passage to lower costs to Americans, including by empowering Medicare to negotiate prescription drug costs.  

“Since I came to Congress, lowering costs by allowing Medicare to negotiate drug prices has been one of my top health care priorities, and now we’re going to see that in action,” said Larson. “Millions of seniors and people with disabilities are saving on insulin and their out-of-pocket prescription drug costs, and soon, Medicare will put money back in Americans’ pockets by negotiating key drug prices for the first time. 

“Last year, as many as 123,000 Connecticut residents enrolled in Medicare Part D used one of the 10 drugs selected for negotiation, with an out-of-pocket mean that was as high as $4,659 per year. I have heard horror stories from constituents who had to cut back or go without their medication because it was too expensive, and that’s flat-out wrong. I voted for the Inflation Reduction Act last year to make progress toward our goal of ensuring no American must choose between their medication and paying their bills, and I am proud of this progress today,” Larson concluded.   

Connecticut-specific information can be found here.  

###